Clinical Trial Update: Platelet Rich Plasma Uterine Infusion [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating Platelet Rich Plasma uterine infusion for infertility and endometriosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Infertility

Drugs mentioned

• Platelet Rich Plasma Uterine Infusion

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Infertility, Endometriosis | Phase 1, Phase 2 | Status: WITHDRAWN